Furthermore, some cancer-associated cGAS mutations abolished the effect of cGAS on L1 repression through disrupting different steps of the CHK2-cGAS-TRIM41-ORF2p regulatory axis, suggesting that cGAS may act as a tumor suppressor. The gene discussed is CHEK2; the disease is cancer.